Skip to content

Degenerative Consequences of Congenital Deafness

Degenerative Consequences of Congenital Deafness

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03866850
Enrollment
34
Registered
2019-03-07
Start date
2019-08-01
Completion date
2023-04-04
Last updated
2023-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Deafness

Brief summary

In this study, the investigators will study one of the basic biophysical properties of the auditory nerve, charge integration, behaviorally (detection threshold versus phase duration functions). The investigators will compare charge integration in two subject groups: congenitally deafened and deafened at a later age in life. The investigators will then examine if behaviorally estimated neural excitation patterns differ between short phase duration and long phase duration stimulation. Lastly, The investigators will measure if speech recognition improves with using long phase duration stimulation, relative to using the standard default short phase duration stimulation. The primary endpoint of the study is speech recognition, and the secondary endpoints are the steepness of the detection threshold versus phase duration functions, and the width of psychophysically estimated neural excitation.

Interventions

BEHAVIORALPhase duration

We will vary the phase duration in the stimulation, and examine detection threshold, spatial spread of neural excitation, and speech recognition as the outcomes.

Sponsors

East Carolina University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum

Inclusion criteria

* Cochlear Nucleus cochlear implant users or Advanced Bionics cochlear implant users * Native speakers of English * Early onset of deafness (\< 3 years of age); no requirement for age at implantation * Late onset of deafness (\> 3 years of age); matched in duration of deafness to the early onset group * Has had device experience for at least one year * Can be child or adult at the time of enrollment

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Slope of the strength duration functionstarting 6 months post award notice and will take up to 4 years to completeSubjects will be measured for detection thresholds as a function of phase duration of the pulse train and the slope of the function will be derived.

Secondary

MeasureTime frameDescription
Psychophysically estimated neural excitation widthstarting 6 months post award notice and will take up to 4 years to completeSubjects will be measured for psychophysical forward-masked spatial tuning curves using stimuli with long and short phase duration.
Speech recognition using long phase durationstarting 6 months post award notice and will take up to 4 years to completeSubjects' speech recognition performance will be evaluated using CUNY and TIMIT sentences with long and short phase duration stimulation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026